Quantopian makes it very clear what they're looking for to allocate capital to: low beta, low single stock exposure, virtually 0 net exposure etc. The trouble is, not everyone has the same investment criteria as Quantopian, including many of us developers.
Many of us have developed investment strategies that, although a viable option to many, don't meet the specific requirements of Quantopian's market neutral hedge fund: i.e. ETF strategies, smart beta strategies, momentum strategies with indicators switching asset allocation etc.
I'd like to see Quantopian develop a service which would allow developers to market and sell their strategies directly. This could be a similar service to Motif's Royalty Program. In their model if people invest in a motif made by a "creator" that person gets a cut of the commission. Couldn't Quantopian set something similar up?
Quantopian can/is theoretically not looking at source code yet are live trading the algorithms. So couldn't this be exposed to common investors? In this model a developer could market his/her algorithm for other investors to use for a low fixed fee per month. That fee could then be split between the developer and Quantopian. This model could represent a decent revenue stream for Quantopian. Yet it also will help motivate developers to not only write more algorithms, but attract both fellow developers and common investors to the Quantopian platform. I would think that the legality and risk here for Quantopian is muted and similar to the current setup? Quantopian and the developers are still not directly holding cash, and users of algorithms could end it at any time.
I think this type of setup is a win-win-win!
- Quantopian can build its community and develop another revenue stream.
- Developers are motivated to create and market algorithms and incentivized to make more sustainable ones that will not only attract investors, but keep them.
- Common investors not interested in writing code but still want access to low cost investment products will now have that source.